r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement.
about
Scientific overview: 2013 BBC plenary symposium on tobacco addiction.Tritium-labelled alkaloids: Synthesis and applications.Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors.Ifenprodil Attenuates Methamphetamine-Induced Behavioral Sensitization and Activation of Ras-ERK-∆FosB Pathway in the Caudate Putamen.Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats.
P2860
r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
r-bPiDI, an α6β2* Nicotinic Re ...... se and Nicotine Reinforcement.
@ast
r-bPiDI, an α6β2* Nicotinic Re ...... se and Nicotine Reinforcement.
@en
type
label
r-bPiDI, an α6β2* Nicotinic Re ...... se and Nicotine Reinforcement.
@ast
r-bPiDI, an α6β2* Nicotinic Re ...... se and Nicotine Reinforcement.
@en
prefLabel
r-bPiDI, an α6β2* Nicotinic Re ...... se and Nicotine Reinforcement.
@ast
r-bPiDI, an α6β2* Nicotinic Re ...... se and Nicotine Reinforcement.
@en
P2093
P2860
P1476
r-bPiDI, an α6β2* Nicotinic Re ...... se and Nicotine Reinforcement.
@en
P2093
Andrew C Meyer
Andrew M Smith
David B Horton
Guangrong Zheng
J Michael McIntosh
Joshua S Beckmann
Linda P Dwoskin
M Pivavarchyk
Michael T Bardo
Peter A Crooks
P2860
P2888
P304
P356
10.1007/S11064-015-1680-4
P577
2015-07-31T00:00:00Z